2 BPC-157 exhibits significant anti-inflammatory properties, which may contribute to its effectiveness in healing inflammatory skin lesions and other tissue injuries
Originally researched for gut repair and tissue healing, BPC-157 is now gaining attention for its role in energy, metabolic function, and age-related decline
Yes, BPC-157 is often combined with other regenerative therapies such as TB-500 (for enhanced tissue repair), physical therapy, proper nutrition, and other peptides depending on your specific goals
Phase 2 dose-finding data The phase 2 trial tested cagrilintide at 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg weekly
Why do two patients get different results from the same peptide
Group five was administered 100 g/kg BPC157 normal saline solution by IM injection once a day for seven consecutive days